Keyword: Particle Sciences
News
07.06.2017
- Lubrizol has announced a $60 million investment in new product solutions, capacity expansion, and additional cGMP manufacturing to strengthen its excipients, polymers, drug...
News
17.06.2016
- Drug product formulation specialist Particle Sciences, part of Lubrizol’s LifeSciences business since September 2015, has added capacity for cGMP sterile powder filling and capsule...
News
11.09.2015
- US-based Lubrizol Corporation has acquired Particle Sciences, a compatriot contract drug developer and manufacturer headquartered at Bethlehem, Pennsylvania. Terms of the...
